-
Sanofi Makes Inactive Polio Vaccine Available to Poor Countries for a $1 a Dose
The tiered pricing allows 73 countries to buy Sanofi's 10-dose presentations for $1 a shot, while middle-income countries will pay $2.04-$2.38, beginning in July.
- Categories
- Health Care
-
Haiti launches anti-cholera vaccination campaign
The Haitian government along with international partners including the World Health Organization launched a vaccination campaign against cholera on Saturday targeting 100,000 people in vulnerable areas of the impoverished Caribbean country.
- Categories
- Health Care
- Region
- Latin America
-
Serum Institute, Bilthovan to slash polio vaccine prices
Pune-based Serum Institute of India Ltd and its Netherlands unit Bilthoven Biologicals BV on Tuesday announced about a 50% reduction in the price of their polio vaccines for the United Nation’s global polio eradication programme.
- Categories
- Health Care
- Tags
- supply chains, vaccines
-
Africa: Mobile Mast Vaccine Storage Project Wins Global Prize
An organisation that uses surplus energy from mobile phone masts to refrigerate vaccines in remote areas was named as the Best Mobile Health Product or Service at the Global Mobile Awards this week.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Developing-World Disease Vaccines Being Prepared for Human Tests
The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
- Categories
- Health Care
- Tags
- public health, vaccines
-
Developing-World Disease Vaccines Being Prepared for Human Tests
The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
- Categories
- Health Care
-
Vaccines to be manufactured locally – President
Local pharmaceutical companies have benefited from Government funding amounting to Gh¢50 million to manufacture Anti-Retroviral Drugs (ARVs) in the country. This was announced by President John Mahama when he delivered the State of the Nation Address to Parliament on Tuesday.
- Categories
- Health Care
- Tags
- vaccines
-
Opinion: The Role of Global Health R&D in the New Development Framework
While everybody recognises that health is an essential precondition for development, the research and innovation dimension of global health has too often been side-lined in the development discourse.
- Categories
- Education, Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.